If you are in your early to mid-40s and something feels off, you are probably not imagining it. Perimenopause symptoms are among the most common yet least discussed changes in women’s health, partly because they arrive gradually, partly because they overlap with stress and busy-life explanations that are easy to accept, and partly because the
For men dealing with low sexual desire or erectile dysfunction that does not respond fully to standard medications, PT-141 for men has become a growing subject of clinical discussion. Erectile dysfunction and low sexual desire in men are two problems that often get grouped together in conversation, and equally often treated as the same thing
For many women, the conversation about low sexual desire starts and ends with a vague acknowledgment that something has changed, followed by a list of lifestyle suggestions and not much else. Sleep better. Reduce stress. Exercise more. Spend quality time with your partner. All reasonable advice, and none of it gets at what is actually
One of the most common questions people bring to a first hormone or peptide therapy consultation is some version of: “I think something is off, but my doctor said my labs are normal.” It is a frustrating place to be. Symptoms are real, they affect quality of life, and yet the results come back without
Search volume for sermorelin grew 233% between August 2024 and August 2025, making it one of the fastest-rising terms in the entire hormone optimization space. That kind of growth does not happen by coincidence. It reflects a genuine shift in how patients and clinicians are thinking about growth hormone support and what options are actually
Interest in tesamorelin has grown significantly over the past year. US search volume exceeded 135,000 monthly searches by early 2026, up nearly 50% in just six months. But unlike many peptides that trend on social media before clinical evidence exists, tesamorelin has a different story: it carries full FDA approval, is supported by two large
